How to treat patients infected with blood-positive pneumococcus.
Blood-positive pneumococcal infections are a serious clinical problem that threatens the life of patients. Treatment of such infections requires the development of individualized treatment programmes, taking into account, inter alia, the specific condition of the patient, the type of bacteria and their resistance, and the sensitivity of the drug. The following are treatments for patients infected with blood-positive pneumococcal infections.
1. Clinical performance observation: First, a doctor is required to examine in detail the patient ‘ s medical history and to observe his or her clinical performance, such as hemorrhaging, cold warfare, rashes, joint pain and so forth, in order to make a preliminary determination as to whether there is an infection. Blood testing: routine tests such as blood routines, blood biochemistry, etc. to understand changes in infection indicators such as the patient’s white-cell count, the ratio of neutral particles, etc. Bacteria culture and pharmacological sensibilities: taking samples of patients’ blood, bone marrow, urine, etc., for bacterology development, identifying the type of bacteria infected. At the same time, drug-sensitization tests are conducted to understand bacteria’ sensitivity to antibiotics and to provide a basis for subsequent antibiotics treatment.
1. Selection of appropriate antibiotics: Based on the results of bacterial culture and drug sensitivity tests, sensitive antibiotics are selected for treatment. The commonly used antibiotics include penicillin, headgillin and vancin. These drugs can contain infection by inhibiting or destroying bacteria.
• Penicillin, such as ammonia sicillin, ammosilin, etc., are applicable to penicillin-sensitive gland positive fungi infections.
• Head bacterium: e.g., head gills, gills, etc., have broad-spectrum resistance and are effective for a wide range of gelatin positive fungi.
• Vancocin: Good antibacterial resistance to positive fungus, such as pyrocococcus, is an important drug for drug-resistant infections. 2. The principle of the use of medicines: the use of antibiotics should be based on the principles of early, adequate, joint and intensive treatment. Early use of drugs can quickly control infection and prevent further deterioration; sufficient use of drugs can ensure effective concentrations in the body to achieve microbicide effects; combined use of drugs can expand antibacterial spectrometry and improve treatment effectiveness; and pharmacological use can completely eliminate bacteria and prevent relapse. 3. Monitoring and adjustment: During treatment, changes in the patient ‘ s condition, including changes in infection indicators such as body temperature, white cell count, etc., should be closely monitored. At the same time, bacterial training and drug sensitivity tests are regularly conducted to understand the changes in the resistance of bacteria and to adjust treatment programmes in a timely manner.
1. Nutritional support: People infected with blood-positive fungi often suffer from malnutrition, and nutritional support needs to be strengthened to improve their immunity. High-protein, high-calorie, high-vitamin diets can be provided, with intestine or intestinal nutritional support where necessary. 2. Treatment of symptoms: Treatment of specific symptoms of the patient, such as physical or pharmaceutical cooling in case of fever, painkillers in case of joint pain. 3. Psychological support: due to the severity of the condition, patients often suffer from negative feelings of anxiety, fear, etc. Medical personnel should provide adequate psychological support to patients and help them build confidence in overcoming disease.
1. Strengthening personal hygiene: keeping the skin clean and dry so as to avoid skin damage; working to wash hands, using mobile water and soap; avoiding close contact with infected persons. 2. Increased immunity: increased exercise and better physical fitness; a reasonable diet with a nutritional balance; avoidance of overwork and adequate sleep. 3. Periodic monitoring: For patients with high-risk factors, such as the elderly, chronically ill, blood routines, biochemicals, etc., should be regularly examined in order to detect and treat infection in a timely manner.
Treatment of haemopositive pneumococcal infections requires a combination of initial diagnosis and bacterial development, antibiotics treatment, support treatment and preventive measures. Through science-based treatment and care, infections can be effectively controlled and patient cure rates and quality of life improved. At the same time, health-care providers should strengthen the health education and psychological guidance of patients and help them to build confidence in overcoming the disease.
